Company Filing History:
2 out of 7 
2 out of 453 Years Active: 2016-2018
Title: Juana Gallar Martínez - Innovator in Ocular Therapeutics
Introduction
Juana Gallar Martínez, based in San Joan d'Alacant, Spain, is a notable inventor recognized for her contributions to the field of ophthalmology. With two patents under her name, she has developed innovative therapeutic compositions aimed at treating ocular conditions that affect patients' quality of life.
Latest Patents
Martínez's latest patents focus on the treatment of ocular irritation and conditions involving tearing. The first patent, "Methods for treating ocular irritation involving tearing by administering modulators of TRPM8," relates to therapeutic compositions for treating dry eye. This invention involves compositions that include a TRPM8 receptor agonist ligand. Additionally, it addresses the treatment of epiphora with compositions comprising a TRPM8 receptor antagonist. Her second patent, "Use of TRPM8 for treating ophthalmic diseases or conditions involving tearing," shares a similar focus on therapeutic applications for dry eye and epiphora, highlighting the potential of TRPM8 modulators in ophthalmic treatments.
Career Highlights
Martínez has worked with prestigious institutions such as Universidad Miguel Hernández de Elche and the Consejo Superior de Investigaciones Científicas (CSIC). Her research and innovations have significantly advanced the understanding and treatment of ocular conditions.
Collaborations
Throughout her career, Juana has collaborated with esteemed colleagues, including Carlos Belmonte Martínez and Antonio Vicente Ferrer Montiel. These collaborations underscore the importance of teamwork in developing cutting-edge solutions in therapeutic medicine.
Conclusion
Juana Gallar Martínez's work represents a significant advancement in ocular therapeutics, with her patents reflecting a deep understanding of the complexities of eye conditions. Her ongoing contributions may pave the way for more effective and innovative treatments, ultimately improving the lives of many patients affected by these issues.